CTRI/2018/07/014924已完成未知
A Randomised comparative study to evaluate the safety and efficacy of Dexmedetomidine versus Propofol for sedation in Mechanically ventilated patients
okmanya Tilak municipal generalhospital and Medical college0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patient requiring postoperative ventillatory support.Patient or relatives giving written consent.Patient for emergency surgeries requiring blood transfusion prior to weaning.
排除标准
- •Patient with known Hypersensetivity to drugs used in study.Hemodynamically unstable patient.Pregnant and lactating women.Patient requiring neuromuscular blockade during sedation.Paitents requiring epidural drug during sedation.Patients with grossly deranged kidneys and liver functions.Patients with airway surgery.
研究者
相似试验
已完成
4 期
A clinical study to see the effects of two different drugs, in patients undergoing laser for angle closure glaucomaCTRI/2017/12/010922Aravind eye hospital152
已完成
4 期
Comparative study in medical management of Neuropathic paiCTRI/2016/08/007163Dr Sourav Chakrabarty100
已完成
3 期
A Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL* as an Adjunct to Sutured Dural RepairCSF leakageleakage of brain fluid10040795NL-OMON36810Omrix Biopharmaceuticals Ltd20
进行中（未招募）
不适用
An investigation of Evicel sealant to assist brain surgeryTissue adhesion/sealing and suture support in neurosurgery and surgical procedures where contact with cerebrospinal fluid or dura mater can occur e.g. otologic, rhinologic, ophthalmic and vertebral surgery.EUCTR2009-016501-41-FIOmrix Biopharmaceuticals Ltd135
进行中（未招募）
不适用
A Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Evicel as an Adjunct to Sutured Dural Repairtissue adhesion/sealing and suture support in neurosurgery and surgical procedures where contact with cerebrospinal fluid or dura mater can occur e.g. otologic, rhinologic, ophthalmic and vertebral surgery.EUCTR2009-016501-41-DEOmrix Biopharmaceuticals Ltd130